19.12.2013 • NewsMergers & Acquisitions (M&A)ArkemaIneos

Announcement on Merged Bids for Kem One Imminent

The fate of French PVC producer Kem One could be decided on Dec. 20, just before most trading activity ceases for the Christmas and New Year's holidays. Only one bidder is left in the running to pull the former Arkema subsidiary out of the mire. The company that filed for bankruptcy at the end of March is Europe's third largest PVC producer (behind Ineos and Solvay), with sales of more than €1 billion.

On Dec. 18, the Commercial Court of Lyon, France, which is handling the insolvency proceedings, announced that two bids had been merged into one - with private equity group OpenGate Capital and industrial Alain de Krassny opting to pool their resources.

The joint bid was to be presented to Kem One's Joint Consultative Committee on Dec. 19, with another hearing scheduled for Dec. 20 to announce what the court called a "final decision."

The assets up for grabs include seven production sites with 1,300 employees at Balan, Saint-Fons, Saint-Auban, Berre, Fos-sur-Mer, Lavéra and Vauvert - all in France. Altogether, KemOne employs 2,600 people at 22 sites in Europe, Asia and North America. 

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.